benzodiazepines

Preferred Label : benzodiazepines;

MeSH definition : A group of two-ring heterocyclic compounds consisting of a benzene ring fused to a diazepine ring.;

MeSH synonym : benzodiazepine compounds;

MeSH hyponym : benzodiazepine;

MeSH Related Number : benzodiazepine; M0Q7802G2B;

Registry Number MeSH : 12794-10-4;

Related CAS MeSH : M0Q7802G2B (Benzodiazepine);

MeSH annotation : do not confuse with BENZODIAZEPINONES;

Wikipedia link : https://en.wikipedia.org/wiki/Benzodiazepine;

Is substance : O;

Details

Origin ID

D001569;

UMLS CUI

C0005064;

ATC code(s)
- benzodiazepine derivatives [ATC Code]
ATC code(s)
- benzodiazepine derivatives [ATC Code]
- benzodiazepine derivatives [ATC Code]
- benzodiazepine derivatives [ATC Code]
- benzodiazepine related drugs [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Benzodiazepines [ICHI section]
- benzodiazepine derivatives [ATC Code]
- benzodiazepine derivatives [ATC Code]
- benzodiazepine derivatives [ATC Code]
- benzodiazepines [EMDN type]
- benzodiazepines [medical devices type]
CISMeF manual mappings
- Benzodiazepine measurement (procedure) [SNOMED CT concept]
False automatic mappings
- Benzodiazepines [ICD-10 Sub-category (who)]
- Benzodiazepines [ICD-10 Sub-category (who)]
- Poisoning by, adverse effect of and underdosing of benzodiazepines [ICD-10 Sub-category]
Indexing information
- benzodiazepine-binding protein p36 [MeSH Supplementary Concept]
- ro 15-3505 [MeSH Supplementary Concept]
Manual BTNT mappings - CISMeF
- Benzodiazepine sedative (substance) [SNOMED CT concept]
Ne pas confondre avec
- benzodiazepinones [MeSH Descriptor]
Record concept(s)
- benzodiazepine [MeSH concept]
- benzodiazepines [MeSH concept]
Related MeSH Supplementary Concept(s)
- (11aS)-8-hydroxy-7-methoxy-1,2,3,11a-tetrahydro-5H-pyrrolo(2,1-c)(1,4)benzodiazepin-5-one [MeSH Supplementary Concept]
- 1,2,3,4-tetrahydrobenzo(e)(1,4)diazepin-5-one [MeSH Supplementary Concept]
- 1,5-benzodiazepin-2-one [MeSH Supplementary Concept]
- 1-(3-(N'-(4-(2-(N-aminosulfonylamidino)ethylthiomethyl)thiazol-2-yl)guanidinomethyl)phenyl)-3-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl)urea [MeSH Supplementary Concept]
- 1-(3-iodophenyl)-3-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo(e)(1,4)diazepin-3-yl)urea [MeSH Supplementary Concept]
- 1-(4'-aminophenyl)-3,5-dihydro-7,8--dimethoxy-2,3-benzodiazepine [MeSH Supplementary Concept]
- 1-(4'-aminophenyl)-3,5-dihydro-7,8-dimethoxy-4H-2m3-benzodiazepine-4-thione [MeSH Supplementary Concept]
- 1-(4-dimethylaminomethylphenyl)-8,9-dihydro-7H-2,7,9a-benzo(cd)azulen-6-one [MeSH Supplementary Concept]
- 1-epi-adpressin C [MeSH Supplementary Concept]
- 1-methyl-6-phenyl-4H-s-triazo-(4,3-alpha)(1,4)benzodiazepinone [MeSH Supplementary Concept]
- 1012-S-acetamide adipic hydrazide sepharose 4B [MeSH Supplementary Concept]
- 1012S [MeSH Supplementary Concept]
- 2,3,4,5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-4-(2-biphenylylcarbonyl)-1H-1,4-benzodiazepine [MeSH Supplementary Concept]
- 2,3-dimethyl-6-phenyl-12H-(1,3)dioxolo(4,5-h)imidazo(1,2-c)(2,3)benzodiazepine [MeSH Supplementary Concept]
- 2-(5-cyclohexyl-1-(2-cyclopentyl-2-oxoethyl)-2-oxo-1,2-dihydro-3H-1,3,4-benzotriazepin-3-yl)-N-(3-(5-oxo-2,5-dihydro-(1,2,4)oxadiazol-3-yl)phenyl)acetamide [MeSH Supplementary Concept]
- 2-amino-4-(methyl(2-methylphenyl)amino)-11H-pyrimido(4,5-b)(1,5)benzodiazepin-6-ium [MeSH Supplementary Concept]
- 2-amino-4-(piperidin-1-yl)-11H-pyrimido(4,5-b)(1,5)benzodiazepin-6-ium [MeSH Supplementary Concept]
- 2-chlorodiazepam [MeSH Supplementary Concept]
- 2-hydroxy-4-methylpyrimido(4,5-b)(1,5)benzodiazepin-5-one [MeSH Supplementary Concept]
- 2-hydroxymethylolanzapine [MeSH Supplementary Concept]
- 2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno(2,3-b)(1,5)benzodiazepine [MeSH Supplementary Concept]
- 2-oxoquazepam [MeSH Supplementary Concept]
- 3-bromo-10-difluoromethyl-9H-imidazo(1,5-a)(1,2,4)triazolo(1,5-d)(1,4)benzodiazepine [MeSH Supplementary Concept]
- 3-ethoxycarbonyl-2-methyl-4-(2-nitrophenyl)-4,11-dihydro-1H-pyrido(2,3-b)(1,5)benzodiazepine [MeSH Supplementary Concept]
- 3-hydroxyphenazepam [MeSH Supplementary Concept]
- 3-tert-butoxycarbonylamino-2-oxo-2,3,4,5-tetrahydro-1,5-benzodiazepine-1-acetic acid methyl ester [MeSH Supplementary Concept]
- 4,5,6,7-tetrahydro-5-methylimidazo(4,5,1-jk)(1,4)benzodiazepin-2(1H)-one [MeSH Supplementary Concept]
- 4,5,6,7-tetrahydroimidazo-(4,5,1- jk)(1,4)benzodiazepin-2 (1 H)-one [MeSH Supplementary Concept]
- 4,5-dihydro-2,3-dimethyl-4-phenyl-3H-1,3-benzodiazepine [MeSH Supplementary Concept]
- 4-(2-hydroxyphenyl)-2-phenyl-2,3-dihydro-1H-1,5-benzodiazepine [MeSH Supplementary Concept]
- 4-(3,5-dihydroxybenzyl)-N-(2-methyl-4-((1-methyl-4,10-dihydropyrazolo(3,4-b)(1,5)benzodiazepin-5(1H)-yl)carbonyl)benzyl)piperazine-1-carboxamide [MeSH Supplementary Concept]
- 4-(3-bromophenyl)-1,3-dihydro-2H-1,5-benzodiazepin-2-thione [MeSH Supplementary Concept]
- 4-cyclohexylmethyl-1-methyl-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione [MeSH Supplementary Concept]
- 4-phenyl-2-trichloromethyl-3H-1,5-benzodiazepine [MeSH Supplementary Concept]
- 5,11-dihydro-pyrido(2,3-b)(1,5)benzodiazepine [MeSH Supplementary Concept]
- 5-(2-chlorophenyl)-7-fluoro-1,2-dihydro-8-methoxy-3-methylpyrazol(3,4b)(1,4)benzodiazepine [MeSH Supplementary Concept]
- 5-phenyl-3-ureido-1,5-benzodiazepine [MeSH Supplementary Concept]
- 6-fluoro-10-(3-(2-methoxyethyl)-4-methylpiperazin-1-yl)-2-methyl-4H-3-thia-4,9-diazabenzo(f)azulene [MeSH Supplementary Concept]
- 7-(4-bromophenyl)-8-phenoxy-4,5-benzo-3-aza-2-nonem [MeSH Supplementary Concept]
- 7-bromo-5-phenyl-1,2-dihydro-2H-1,4-benzodiazepin-2-one [MeSH Supplementary Concept]
- 7-bromo-5-phenyl-dihydro-3H-1,4-benzodiazepine [MeSH Supplementary Concept]
- 7-chloro 5-(2-chlorophenyl)-1,3-dihydro-2H-(1,4)-benzodiazepine-2-thione [MeSH Supplementary Concept]
- 7-chloro-1,3-dihydro-1-(1,1-dimethylethyl)-5-(2-fluorophenyl)-2H-1,4-benzodiazepin-2-one [MeSH Supplementary Concept]
- 7-chloro-1,3-dihydro-3-hemisuccinyloxy-5-phenyl-1,4-benzodiazepin-2-one [MeSH Supplementary Concept]
- 7-chloro-4-(cyclohexylmethyl)-1-methyl-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione [MeSH Supplementary Concept]
- 7-cyano-2,3,4,5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3-(phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine [MeSH Supplementary Concept]
- 7-methoxy-8-(5-(4-(1,3-benzothiazol-2-yl)-2-methoxyphenoxy)pentyl)oxy-(11aS)1,2,3,11a-tetra-hydro-5H-pyrrolo(2,1-c)(1,4)benzodiazepin-5-one [MeSH Supplementary Concept]
- 8,9-dimethoxy-6-(4-bromophenyl)-11H-(1,2,4)triazolo(4,5-c)(2,3)benzodiazepin-3(2H)-one [MeSH Supplementary Concept]
- 8-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-2-one [MeSH Supplementary Concept]
- 8-chloro-6-(4-phenethyl-1-piperazinyl)-11H-pyrido(2,3-b)(1,4)benzodiazepine [MeSH Supplementary Concept]
- 8-chlorotetrahydroimidazo(4,5,1-jk)(1,4)-benzodiazepin-2(1H)-thione [MeSH Supplementary Concept]
- 8-ethynyl-6-(2'-pyridine)-4H-2,5,10b-triazabenzo(e)azulene-3-carboxylic acid ethyl ester [MeSH Supplementary Concept]
- 8-fluoro-12-(4-methylpiperazin-1-yl)-6H-(1)benzothieno(2,3-b)(1,5)benzodiazepine [MeSH Supplementary Concept]
- 9-aminonevirapine [MeSH Supplementary Concept]
- 9a,9b,14b,14c-tetraphenylbenzo(1,2-h-4,5-h')dicyclohepta(1,2,3-bc)glycoluril [MeSH Supplementary Concept]
- AHR 11797 [MeSH Supplementary Concept]
- AX-A411-BS [MeSH Supplementary Concept]
- BAY 1238097 [MeSH Supplementary Concept]
- BD-1158 [MeSH Supplementary Concept]
- BDA 250 [MeSH Supplementary Concept]
- BDA 452 [MeSH Supplementary Concept]
- BIM 18216 [MeSH Supplementary Concept]
- BMS-986115 [MeSH Supplementary Concept]
- BMS225975 [MeSH Supplementary Concept]
- BZA 5B [MeSH Supplementary Concept]
- BZA-2B [MeSH Supplementary Concept]
- Bz-423 [MeSH Supplementary Concept]
- CGS 15040A [MeSH Supplementary Concept]
- CL 385004 [MeSH Supplementary Concept]
- CP 1414S [MeSH Supplementary Concept]
- CR 2945 [MeSH Supplementary Concept]
- DHES0815A [MeSH Supplementary Concept]
- DMP 406 [MeSH Supplementary Concept]
- DRH-417 [MeSH Supplementary Concept]
- EGIS 7649 [MeSH Supplementary Concept]
- EGIS-10608 [MeSH Supplementary Concept]
- EGIS-8332 [MeSH Supplementary Concept]
- EVT 201 [MeSH Supplementary Concept]
- FG 8119 [MeSH Supplementary Concept]
- GI 181771X [MeSH Supplementary Concept]
- GP 55129 [MeSH Supplementary Concept]
- GWL 78 [MeSH Supplementary Concept]
- GYKI 47261 [MeSH Supplementary Concept]
- GYKI 52466 [MeSH Supplementary Concept]
- GYKI 52713 [MeSH Supplementary Concept]
- GYKI 53655 [MeSH Supplementary Concept]
- GYKI 53665 [MeSH Supplementary Concept]
- GYKI 53784 [MeSH Supplementary Concept]
- ID 622 [MeSH Supplementary Concept]
- ID 690 [MeSH Supplementary Concept]
- KC 2846 [MeSH Supplementary Concept]
- KC 5944 [MeSH Supplementary Concept]
- Ka-2547 [MeSH Supplementary Concept]
- L 364373 [MeSH Supplementary Concept]
- L 368935 [MeSH Supplementary Concept]
- L 663581 [MeSH Supplementary Concept]
- L 735821 [MeSH Supplementary Concept]
- LE 511 [MeSH Supplementary Concept]
- LG325 [MeSH Supplementary Concept]
- MEDI0641 [MeSH Supplementary Concept]
- N-(2-hydroxyethyl)lorazepam [MeSH Supplementary Concept]
- N-desmethylclobazam [MeSH Supplementary Concept]
- N-desmethylmetaclazepam [MeSH Supplementary Concept]
- N-desmethylquazepam [MeSH Supplementary Concept]
- N-desmethyltimelotem [MeSH Supplementary Concept]
- N-p-tosyl-1,5-benzodiazepin-2-one [MeSH Supplementary Concept]
- NNC 13-8241 [MeSH Supplementary Concept]
- PF-184563 [MeSH Supplementary Concept]
- PGW5 compound [MeSH Supplementary Concept]
- PWZ-029 [MeSH Supplementary Concept]
- QH-II-66 [MeSH Supplementary Concept]
- R 79882 [MeSH Supplementary Concept]
- R 82150 [MeSH Supplementary Concept]
- R 86183 [MeSH Supplementary Concept]
- R-82913 [MeSH Supplementary Concept]
- R1498 compound [MeSH Supplementary Concept]
- RL 218 [MeSH Supplementary Concept]
- RL 236 [MeSH Supplementary Concept]
- RO 4882224 [MeSH Supplementary Concept]
- RO0281501 [MeSH Supplementary Concept]
- RS 678 [MeSH Supplementary Concept]
- RS 779 [MeSH Supplementary Concept]
- RU 32007 [MeSH Supplementary Concept]
- RWJ-351647 [MeSH Supplementary Concept]
- RY 008 [MeSH Supplementary Concept]
- RY 023 [MeSH Supplementary Concept]
- RY 024 [MeSH Supplementary Concept]
- RY 80 [MeSH Supplementary Concept]
- Ro 06-9098-000 [MeSH Supplementary Concept]
- Ro 16-0521 [MeSH Supplementary Concept]
- S 8510 [MeSH Supplementary Concept]
- S44819 [MeSH Supplementary Concept]
- SAS 646 [MeSH Supplementary Concept]
- SC 32855 [MeSH Supplementary Concept]
- TKM0150 [MeSH Supplementary Concept]
- TS 941 [MeSH Supplementary Concept]
- U 34599 [MeSH Supplementary Concept]
- U 51477 [MeSH Supplementary Concept]
- U46,195 [MeSH Supplementary Concept]
- VP 339 [MeSH Supplementary Concept]
- VP 365 [MeSH Supplementary Concept]
- WAY-162720 [MeSH Supplementary Concept]
- YM 022 [MeSH Supplementary Concept]
- ZIMET 54-79 [MeSH Supplementary Concept]
- adinazolam [MeSH Supplementary Concept]
- adinazolam mesylate [MeSH Supplementary Concept]
- alpha5IA-II [MeSH Supplementary Concept]
- aptazapine [MeSH Supplementary Concept]
- auranthine [MeSH Supplementary Concept]
- balovaptan [MeSH Supplementary Concept]
- benzomalvin A [MeSH Supplementary Concept]
- benzomalvin B [MeSH Supplementary Concept]
- benzomalvin C [MeSH Supplementary Concept]
- benzomalvin E [MeSH Supplementary Concept]
- benzopyrano(4,3-c)-1,5-benzodiazepine [MeSH Supplementary Concept]
- biotin-1012-S [MeSH Supplementary Concept]
- camazepam [MeSH Supplementary Concept]
- carpipramine [MeSH Supplementary Concept]
- chicamycin A [MeSH Supplementary Concept]
- chicamycin B [MeSH Supplementary Concept]
- chlordesmethyldiazepam [MeSH Supplementary Concept]
- cinolazepam [MeSH Supplementary Concept]
- circumdatin C [MeSH Supplementary Concept]
- clazepam [MeSH Supplementary Concept]
- clonazolam [MeSH Supplementary Concept]
- cloxazolam [MeSH Supplementary Concept]
- demoxepam [MeSH Supplementary Concept]
- deschloroetizolam [MeSH Supplementary Concept]
- desmethylclobazam [MeSH Supplementary Concept]
- diethyl-(Z)-2-(5,7-diphenyl-1,3,4-oxadiazepin-2-yl)-2-butenedioate [MeSH Supplementary Concept]
- dipitramine [MeSH Supplementary Concept]
- doxefazepam [MeSH Supplementary Concept]
- ethyl 8-fluoro-6-(3-nitrophenyl)-4H-imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylate [MeSH Supplementary Concept]
- ethyl loflazepate [MeSH Supplementary Concept]
- ethyl-4,8-dimethyl-2-(pyridin-2-yl)-2,5-dihydro-1,5-benzodiazepine-3-carboxylate [MeSH Supplementary Concept]
- ethyl-4-methyl-2-(pyridin-2-yl)-2,5-dihydro-1,5-benzodiazepine-3-carboxylate [MeSH Supplementary Concept]
- ethyl-8-ethyl-5,6-dihydro-5-methyl-6-oxo-4H-imidazo(1,5a)(1,4)benzodiazepine-3-carboxylate [MeSH Supplementary Concept]
- ethyl-8-trimethylsilyl-2-acetyl-12,12a-dihydro-9-oxo-9H,11H-azeto(2,1-c)imidazo(1,5a)-1,4-benzodiazepine [MeSH Supplementary Concept]
- evacetrapib [MeSH Supplementary Concept]
- fletazepam [MeSH Supplementary Concept]
- flualprazolam [MeSH Supplementary Concept]
- flubromazolam [MeSH Supplementary Concept]
- fludiazepam [MeSH Supplementary Concept]
- flumezapine [MeSH Supplementary Concept]
- flunitrazolam [MeSH Supplementary Concept]
- fluoroquinolone-pyrrolo(2,1-c)(1,4)benzodiazepine [MeSH Supplementary Concept]
- flutazolam [MeSH Supplementary Concept]
- gidazepam [MeSH Supplementary Concept]
- girisopam [MeSH Supplementary Concept]
- halazepam [MeSH Supplementary Concept]
- haloxazolam [MeSH Supplementary Concept]
- imidazenil [MeSH Supplementary Concept]
- indiplon [MeSH Supplementary Concept]
- isonoraptazepine [MeSH Supplementary Concept]
- ketazolam [MeSH Supplementary Concept]
- lepirazepam [MeSH Supplementary Concept]
- limazepine B1 [MeSH Supplementary Concept]
- limazepine D [MeSH Supplementary Concept]
- limazepine G [MeSH Supplementary Concept]
- limazepine h [MeSH Supplementary Concept]
- lixivaptan [MeSH Supplementary Concept]
- loflazepic acid [MeSH Supplementary Concept]
- loncastuximab tesirine [MeSH Supplementary Concept]
- lotrafiban [MeSH Supplementary Concept]
- metaclazepam [MeSH Supplementary Concept]
- metizolam [MeSH Supplementary Concept]
- mexazolam [MeSH Supplementary Concept]
- mmy-SJG compound [MeSH Supplementary Concept]
- molibresib [MeSH Supplementary Concept]
- mono-N-demethyladinazolam [MeSH Supplementary Concept]
- nerisopam [MeSH Supplementary Concept]
- norflutoprazepam [MeSH Supplementary Concept]
- odevixibat [MeSH Supplementary Concept]
- olanzapine propan-2-ol hemisolvate monohydrate [MeSH Supplementary Concept]
- olanzapine propan-2-one hemisolvate monohydrate [MeSH Supplementary Concept]
- olanzapine-fluoxetine combination [MeSH Supplementary Concept]
- oxazolam [MeSH Supplementary Concept]
- oxoprothracarcin [MeSH Supplementary Concept]
- phenazepam [MeSH Supplementary Concept]
- pinazepam [MeSH Supplementary Concept]
- prothracarcin [MeSH Supplementary Concept]
- psyton [MeSH Supplementary Concept]
- pynazolam [MeSH Supplementary Concept]
- pyrazolam [MeSH Supplementary Concept]
- pyrrolo(2,1-c)(1,4) benzodiazepine-3,11-dione [MeSH Supplementary Concept]
- pyrrolo(2,1-c)(1,4)benzodiazepine [MeSH Supplementary Concept]
- quazepam [MeSH Supplementary Concept]
- quino(7,8-b)benzodiazepine [MeSH Supplementary Concept]
- remimazolam [MeSH Supplementary Concept]
- ro 14-5974 [MeSH Supplementary Concept]
- ro 14-7437 [MeSH Supplementary Concept]
- ro 15-4513 [MeSH Supplementary Concept]
- ro 19-0528 [MeSH Supplementary Concept]
- ro 23-0364 [MeSH Supplementary Concept]
- ro 24-7429 [MeSH Supplementary Concept]
- ro 48-6791 [MeSH Supplementary Concept]
- ro 48-6792 [MeSH Supplementary Concept]
- ro 48-8684 [MeSH Supplementary Concept]
- ro 5-3438 [MeSH Supplementary Concept]
- ro 7-0213 [MeSH Supplementary Concept]
- sarmazenil [MeSH Supplementary Concept]
- sch 23324 [MeSH Supplementary Concept]
- sibanomicin [MeSH Supplementary Concept]
- talampanel [MeSH Supplementary Concept]
- tampramine fumarate [MeSH Supplementary Concept]
- tarazepide [MeSH Supplementary Concept]
- tetrazepam [MeSH Supplementary Concept]
- tetrazolo(1,5-a)(1,4)benzodiazepine [MeSH Supplementary Concept]
- tibenzonium iodide [MeSH Supplementary Concept]
- tifluadom [MeSH Supplementary Concept]
- tilimycin [MeSH Supplementary Concept]
- timelotem [MeSH Supplementary Concept]
- tofisopam [MeSH Supplementary Concept]
- triazolo(4,3-d)benzodiazepine [MeSH Supplementary Concept]
- triazulenone [MeSH Supplementary Concept]
- triflubazam [MeSH Supplementary Concept]
- tripitramine [MeSH Supplementary Concept]
- uldazepam [MeSH Supplementary Concept]
- uxepam [MeSH Supplementary Concept]
- vadastuximab talirine [MeSH Supplementary Concept]
See also (suggested by CISMeF)
- receptors, GABA-A [MeSH Descriptor]
See also inter- (CISMeF)
- Benzodiazepine (substance) [SNOMED CT concept]
- Benzodiazepine Measurement [NCIt concept]
- Benzodiazepines.other [LOINC component]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Benzodiazepine [NCIt concept]
- Benzodiazepines [ICD-10 Sub-category (who)]
- Benzodiazepines [LOINC component]
- benzodiazepine, nos [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients